Arun Rangaswami
Pediatric Hematology-Oncology · Palo Alto, CANPI 1326173642
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pediatric hematology-oncology clinicians in CA, where the typical reported total is $536.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 48 payments — averaging $15,580 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$526K
- Incyte Corporation$118K
- Pfizer$47K
- E.r. Squibb & Sons, L.L.C.$21K
- Takeda Pharmaceuticals U.S.A., Inc.$20K
- Daiichi Sankyo Inc.$16K
How this compares
$0 in reported general payments places this provider in the 5th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Palo Alto
- Philip PizzoPalo Alto$2.6M
- Elysia AlvarezPalo Alto$200K
- Christopher DvorakPalo Alto$144K
- Jessie AlexanderPalo Alto$70K
- John CurnuttePalo Alto$50K
- Crystal MackallPalo Alto$44K
- Glaivy BatsuliPalo Alto$40K
- Michael LinkPalo Alto$37K
- Tami JohnPalo Alto$32K
- Orly KleinPalo Alto$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.